NEERVANNAN SESHADRI (Chief Operating Officer) sold 11.7% of their position (11.32K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $772.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/19/2026ACC: 0001827584-26-000009
Officer· Chief Operating Officer
Since Oct 2020
-11.32K
Net shares
Net seller
$772.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
11.32K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.13K
Price / share
$69.42
Trade value
$216.94K
% of position
3.2%
3/17/2026
97.10K→93.98K
Common Stock
Direct
Shares
−3.61K
Price / share
$68.71
Trade value
$248.04K
% of position
3.8%
3/18/2026
93.98K→90.37K
Common Stock
Direct
Shares
−4.59K
Price / share
$67.00
Trade value
$307.46K
% of position
5.1%
3/19/2026
90.37K→85.78K
Total
Net shares
−11.32K
Net value
-$772.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −3.13K | $69.42 | $216.94K | 3.2% | 97.10K | 93.98K |
| Common Stock Direct | 3/18/2026 | S · Sale | −3.61K | $68.71 | $248.04K | 3.8% | 93.98K | 90.37K |
| Common Stock Direct | 3/19/2026 | S · Sale | −4.59K | $67.00 | $307.46K | 5.1% | 90.37K | 85.78K |
| Total | −11.32K | -$772.44K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned475.00
Total
475.00 indirect475.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 475.00 | Indirect |
| Total | 475.00 | 475.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported